Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 10/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | PTGES | O14684 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SLC26A4 | O43511 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6488086 | 0.92 | ALOX5AP (0.42) | ALOX5APPPARGTP53MAPTMEN1 | |
| SCHEMBL6491428 | 0.90 | BCL2 (0.46) | ALOX5APPPARGTP53MAPT | |
| SCHEMBL6500310 | 0.88 | ALOX5AP (0.40) | ALOX5APALOX5PPARGTP53MAPT | |
| SCHEMBL6500643 | 0.88 | ALOX5AP (0.40) | ALOX5APPTGESALOX5LTC4S | |
| SCHEMBL6492244 | 0.87 | PPARG (0.46) | ALOX5APPPARG | |
| SCHEMBL6500991 | 0.86 | ALOX5AP (0.42) | ALOX5APPPARGTP53MAPT | |
| SCHEMBL6502905 | 0.83 | PIK3C2B (0.41) | ALOX5APEGLN1PTGESALOX5LTC4S | |
| SCHEMBL6492387 | 0.82 | PPARG (0.46) | ALOX5APPPARGTP53 | |
| SCHEMBL6500738 | 0.81 | PIK3C2B (0.38) | ALOX5APPTGESALOX5LTC4STP53 | |
| SCHEMBL6503527 | 0.81 | PIK3C2B (0.38) | ALOX5APPTGESALOX5LTC4S |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | ALOX5AP 4663/4885EGLN1 997/4885PTGES 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.